MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1247)	7/26/1999 10:26:00 AM
From: David Cathcart	Read Replies (1) of 1826

Thank you Rick for the comments re. Salagen and Orphan Drug status. <<Not that any of that has anything to do with current management. BTW, what is Blitzer doing these days? Trying to beat the August doldrums in France?>> I have no real idea what is going on, except for the fact that big changes are being made in top management. As far as the Euro deal for MGI-114 and summer vacations, you guess is as good as mine. I know your thoughts in that area and I respect them. What are your thoughts on the deal with the PNU drug Azulfidine? David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next